Saverio Alvaro

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

Francesco Carubbi, Paola Cipriani, Alessandra Marrelli et al. · Arthritis Research & Therapy · 2013 · 175 citations · Full text

Immunology, Immunotherapy, Psoriatic Arthritis +23

Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1<b>β</b>via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients

Piero Ruscitti, Paola Cipriani, Paola Di Benedetto et al. · Clinical & Experimental Immunology · 2015 · 131 citations · Full text

Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial

Piero Ruscitti, Francesco Masedu, Saverio Alvaro et al. · PLoS Medicine · 2019 · 130 citations · Full text

Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine

Paola Cipriani, Alessandra Marrelli, Paola Di Benedetto et al. · Angiogenesis · 2013 · 64 citations

Regenerative Medicine, Tissue Engineering, Systemic Scleroderma +11

Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study

Piero Ruscitti, Paola Cipriani, Francesco Masedu et al. · PLoS ONE · 2017 · 48 citations · Full text